Book icon with persian name of Pubnito
  • Store
  • Library
  • Your Cart


    Total Items:0

    View Cart

    Frontiers in Clinical Drug Research - Diabetes and Obesity: Volume 2

    Frontiers in Clinical Drug Research - Diabetes and Obesity: Volume 2

    Atta-ur-Rahman

    "Frontiers in Clinical Drug Research – Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research. The second volume of this series features 7 reviews presenting updates on hormones and several classes of drugs: Osteocalcin action in glucose metabolism Sodium-glucose co-transporter 2 (SGLT2) inhibitors Glucagon-like peptide-1 (GLP-1) mimetics Dipeptidyl peptidase 4 (DPP-4) inhibitors New drugs in clinical trial and commercial phases" "Frontiers in Clinical Drug Research – Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research. The second volume of this series features 7 reviews presenting updates on hormones and several classes of drugs: Osteocalcin action in glucose metabolism Sodium-glucose co-transporter 2 (SGLT2) inhibitors Glucagon-like peptide-1 (GLP-1) mimetics Dipeptidyl peptidase 4 (DPP-4) inhibitors New drugs in clinical trial and commercial phases"

    Book Format

    Book License

    $ 79.00

    Reviews

    Rating Snapshot

    Select a row below to filter reviews.

    0

    0

    0

    0

    0

    0

    Overall

    Average Customer Ratings

    Review for this Book

    Share your thoughts with other readers

    More Information

    Description of Frontiers in Clinical Drug Research - Diabetes and Obesity: Volume 2

    "Frontiers in Clinical Drug Research – Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatme

    Additional Information

    Vendor

    Publish Date

    2016 Jun 07

    Authors
    Atta-ur-Rahman

    ISBN

    9781681081854

    About the authors

    Atta-ur-Rahman
    Atta-ur-Rahman
    Atta-ur-Rahman

    Table of content

    logo

    English

    Powered by PUBNiTO | © 2024 Notion Wave Inc.